| 1 |
31227006 | miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. | 2019 Jun 21 |
2 |
| 2 |
27572607 | Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. | 2016 Sep |
3 |
| 3 |
27748799 | Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells. | 2016 Dec |
1 |
| 4 |
25589619 | The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. | 2015 Apr 1 |
1 |